|
Volumn 18, Issue 5, 2006, Pages 549-551
|
Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension secondary to non-cirrhotic perisinusoidal hepatic fibrosis
|
Author keywords
Antineoplastic combined chemotherapy protocols; Portal hypertension; Transjugular intrahepatic portosystemic shunt
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
LACTULOSE;
METHOTREXATE;
PREDNISONE;
SOMATOSTATIN;
VINDESINE;
ADULT;
ANAMNESIS;
ARTICLE;
CANCER CHEMOTHERAPY;
CASE REPORT;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
DOPPLER FLOWMETRY;
ECHOGRAPHY;
ELECTRON MICROSCOPY;
ESOPHAGUS VARICES BLEEDING;
EXTERNAL BEAM RADIOTHERAPY;
HEPATIC ENCEPHALOPATHY;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
LABORATORY TEST;
LIVER BIOPSY;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
LIVER SINUSOID;
MALE;
NONHODGKIN LYMPHOMA;
PHYSICAL EXAMINATION;
PORTAL HYPERTENSION;
PORTAL PHLEBOGRAPHY;
PORTAL VEIN THROMBOSIS;
PORTOSYSTEMIC ANASTOMOSIS;
PRIORITY JOURNAL;
SEMINOMA;
ESOPHAGEAL AND GASTRIC VARICES;
ESOPHAGOSCOPY;
GASTROINTESTINAL HEMORRHAGE;
HUMANS;
LIVER CIRRHOSIS;
MALE;
MIDDLE AGED;
PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;
|
EID: 33744828710
PISSN: 0954691X
EISSN: None
Source Type: Journal
DOI: 10.1097/00042737-200605000-00017 Document Type: Article |
Times cited : (5)
|
References (8)
|